ReviewInternational journal of nanomedicine2026
Radiolabeled Iron-Based Nanomaterials for Cancer Diagnosis and Therapy.
Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer remains one of the leading causes of death worldwide, with diagnosis and treatment continuing to pose significant challenges. In recent years, iron-based nanomaterials (iron oxide-based nanomaterials, iron-based complex conjugates) have garnered unprecedented attention due to their excellent functionality, superior biocompatibility and potential for multifunctional integration. Due to the non-specific nature of radionuclides. Their integration with nanomaterials offers promising opportunities for precise cancer diagnosis and effective treatment by enabling targeted delivery, controlled release, and synergistic combination therapies. This review systematically elucidates the latest advancements in radiolabeled iron-based nanomaterials for cancer diagnosis and therapy, with a focus on radiolabeling methods, multimodal imaging, and the combination of radiotherapy with various treatment modalities, including photothermal therapy (PTT), magnetic hyperthermia therapy (MHT), photodynamic therapy (PDT), immunotherapy (IT), and chemodynamic therapy (CDT). Finally, the prospects for the development of radiolabeled iron-based nanomaterials are discussed, along with key research priorities for the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.